References
- Ball J., Ross A. The Effectiveness of Methadone Maintenance Treatment. Springer-Verlag, New York 1986; 242
- Bell J., Fernandes D., Batey R. Heroin users seeking methadone treatment. Medical Journal of Australia 1990; 152: 361–4
- Caplehom J. R. M. A comparison of private and public methadone maintenance patients. Drug and Alcohol Review 1992; 11: 43–49
- Cohen J., Schamroth A., Nazareth I., Johnson M., Graham S., Thomson D. Problem drug use in a central London general practice. British Medical Journal 1992; 306(6835)
- Collins D. J., Lapsley H. M. Estimating the economic costs of Drug Abuse in Australia. National Campaign Against Drug Abuse. Australian Government Publishing Service, Canberra 1991, Monograph Series No. 15
- Commonwealth Department of Health. National Campaign Against Drug Abuse; Campaign documents. Australian Government Publishing Service, Canberra 1985, Commonwealth Tables, New South Wales Methadone Program, (1991–1993) Drug and Alcohol Directorate, New South Wales Health Department
- D'Aunno T., Vaughan T. E. Variations in methadone treatment practices; results from a national study. Journal of the American Medical Association 1992; 267: 253–8
- Dole V. P., Nyswander M. E. A medical treatment for diacetylmorphine (heroin) addiction. Journal of the American Medical Association 1965; 193: 80–84
- Gaughwin M., Dodding J., Ali R. Hepatitis C and the history of injectomg drug use in South Australia [letter]. Medical Journal of Australia 1994; 161: 286–287
- Goldstein A., Hansteen R. W., Horns W. H. Control of methadone dosage by patients. Journal of the American Medical Association 1975; 234: 734–737
- Greenwood J. Creating a new drug service in Edinburgh. British Medical Journal 1990; 300: 587–9
- Hargreaves W. A. Methadone dosage and duration for maintenance treatment. Research on the Treatment of Narcotic Addiction: State of the Art, J. R. Cooper, F. Altman, B. S.D. Brown Szechowicz. NIDA, U.S. Department of Health and Human Sciences, Maryland 1983; 1
- Havassy B., Hargreaves W. A. Self-regulation of dose in methadone maintenance with contingent privileges. Addictive Behaviors 1979; 4: 31–38
- Holman C. D. J., Armstrong B. K., Arias L. N., Martin C. A., Hatton W. M., Hayward L. D., Salmon M. A., Shean R. E., Waddell V. P. The quantification of drug caused morbidity and mortality in Australia. Commonwealth Department of Community Service and Health, Canberra. Ministerial Council on Drug Strategy. National Methadone Guidelines. Published by the Australian Government Publishing Service, Canberra 1988
- Land P., Zenker C. Methadone Treatment of Drug Addicts in Bremen Research Results. Sucht 1994; 4: 253–265
- Novick D. M., Joseph H., Croxson T. S., Salsitz E. A., Wang G., Richman B. L., Poretsky L., Keefe J. B., Whimbey E. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine 1990; 150: 15–25
- Novick D. M., Richman B. L., Friedman J. M., Friedman J. E., Wilson J. P., Townley A., Kreek M. J. The medical status of methadone maintenance patients in treatment for 11–18 years. Drug and Alcohol Dependence 1993; 33: 235–245
- Robinson G. M., Thornton N. Methadone in general practice. New Zealand Medical Journal 1994, Jan 26[Letter]
- Tennant F. S. Inadequate Plasma Concentrations in Some High-Dose Methadone Maintenance Patients. American Journal of Psychiatry 1987; 144: 1349–1350
- Ward J., Mattick R. P., Hall W. Key Issues In Methadone Maintenance Treatment. NSW University Press Ltd. 1992; 272–273
- Wilson P., Watson R., Ralston G. E. Methadone maintenance in general practice: patients, workload, and outcomes. British Medical Journal 1994; 309: 641–4